We are live on ! Find out more
ASXC

Asensus Surgical, Inc.

Delisted

ASXC was delisted on the 21st of August, 2024.

82 hedge funds and large institutions have $3.22M invested in Asensus Surgical, Inc. in 2020 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

281% more call options, than puts

Call options by funds: $122K | Put options by funds: $32K

64% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 14

25% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 16

1% more funds holding

Funds holding: 8182 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

56% less capital invested

Capital invested by funds: $7.37M → $3.22M (-$4.15M)

Holders
82
Holders Change
+1
Holders Change %
+1.23%
% of All Funds
1.81%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
20
Increased
23
Reduced
14
Closed
16
Calls
$122K
Puts
$32K
Net Calls
+$90K
Net Calls Change
+$154K
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Sabby Management
Florida
$619K +$1.84M +1,760,262 New
BlackRock
2
BlackRock
New York
$418K +$189K +180,753 +18%
MCM
3
Masters Capital Management
Georgia
$363K +$813K +779,129 +307%
Vanguard Group
4
Vanguard Group
Pennsylvania
$250K -$34.2K -32,715 -4%
First Trust Advisors
5
First Trust Advisors
Illinois
$218K +$67.3K +64,425 +12%
SHI
6
SV Health Investors
Massachusetts
$179K
Russell Investments Group
7
Russell Investments Group
United Kingdom
$148K +$440K +421,670 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$119K +$162K +155,287 +84%
State Street
9
State Street
Massachusetts
$100K +$297K +284,185 New
Mirae Asset Global Investments
10
Mirae Asset Global Investments
South Korea
$92K -$37.9K -36,326 -12%
Northern Trust
11
Northern Trust
Illinois
$79K +$73.6K +70,496 +46%
PCM
12
Perkins Capital Management
Minnesota
$79K +$234K +224,117 New
Two Sigma Investments
13
Two Sigma Investments
New York
$73K +$94.4K +90,399 +77%
Charles Schwab
14
Charles Schwab
California
$57K +$60.6K +58,085 +57%
Invesco
15
Invesco
Georgia
$45K +$135K +129,054 New
UBS Group
16
UBS Group
Switzerland
$44K -$51.6K -49,423 -28%
Citadel Advisors
17
Citadel Advisors
Florida
$32K +$94.8K +90,840 New
Morgan Stanley
18
Morgan Stanley
New York
$27K -$43.4K -41,562 -35%
Two Sigma Advisers
19
Two Sigma Advisers
New York
$24K +$60.2K +57,624 +541%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$23K -$76 -73 -0.1%
Millennium Management
21
Millennium Management
New York
$23K +$24.6K +23,591 +57%
CS
22
Credit Suisse
Switzerland
$22K +$64.8K +62,097 New
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
$18K +$2.74K +2,623 +5%
Wells Fargo
24
Wells Fargo
California
$16K +$40.6K +38,900 +439%
Goldman Sachs
25
Goldman Sachs
New York
$12K -$5.73K -5,490 -14%

ASXC Hedge Fund Activity: Q1 2020 in Review

82 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q1 2020, worth a combined $3.22M — down 56% from $7.37M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new ASXC positions and 16 closed out — a net gain of 4 holders — while 23 added to existing stakes and 14 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $1.84M. The largest seller was Nuveen, exiting entirely with an estimated $101K sold.

  • 82 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q1 2020, up from 81 in Q4 2019.
  • Funds reported $3.22M of Asensus Surgical, Inc. stock for Q1 2020, down 56% quarter-over-quarter.
  • 20 funds opened new Asensus Surgical, Inc. positions in Q1 2020 and 16 closed out, a net change of +4 holders.
  • The largest Asensus Surgical, Inc. buyer in Q1 2020 was Sabby Management, an estimated $1.84M added.
  • The largest Asensus Surgical, Inc. seller in Q1 2020 was Nuveen, an estimated $101K sold.

Based on aggregated 13F filings for Q1 2020.